Sprint Bioscience
Develops and out-licenses preclinical oncology drug candidates using an FBDD platform.
SPRINT | ST
Overview
Corporate Details
- ISIN(s):
- SE0006343745
- LEI:
- 5493006ED74WIIQOKC56
- Country:
- Sweden
- Address:
- C/O NOVUM, 141 57 Huddinge
- Website:
- https://sprintbioscience.com/en/
Description
Sprint Bioscience is a pharmaceutical company specializing in the early-stage development of innovative drug candidates for oncology. The company utilizes a fragment-based drug discovery (FBDD) platform to efficiently identify and advance small-molecule therapies targeting difficult-to-treat cancers. Its business model is centered on out-licensing these drug programs to global pharmaceutical companies during the preclinical phase for further development and commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-06-13 16:00 |
Proventus Bioscience Breaks Ground in Quebec
|
English | 9.7 KB |
Automate Your Workflow. Get a real-time feed of all Sprint Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sprint Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sprint Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
